Emcure Pharma PAT rises 25 pc to Rs 251 cr in Q2

Emcure Pharmaceuticals reported a significant 25% rise in profit after tax to Rs 251 crore for the September quarter, driven by robust sales in both domestic and international markets. Revenue from operations also saw an increase, reaching Rs 2,270 crore.

Read More

New Maharashtra rule to impede Tata Trustees’ plans

A new Maharashtra government rule limits lifetime trustees. This ordinance will affect Tata Trusts’ governance structure. Perpetual trustees will now be a minority on trust boards. This change comes after Tata Trusts decided to grant lifetime terms to existing trustees.…

Read More